Results 171 to 180 of about 11,084,548 (300)

High-Pressure Phase Transition of Micro- and Nanoscale HoVO4 and High-Pressure Phase Diagram of REVO4 with RE Ionic Radius

ACS Omega, 2018
Junbo Gong, Xiaodong Fan, Rucheng Dai, Zhongping Wang, Zejun Ding, Zengming Zhang   +5 more
doaj   +1 more source

Seismicity diagnostic of permeability creation from centimeter to subkilometer scales in crystalline rock during shear stimulation. [PDF]

Sci Adv
Yu P, Eijsink A, Wang J, Marone C, Elsworth D.   +4 more
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential. [PDF]

Rapid Commun Mass Spectrom
Möller T, Krug O, Thevis M.
europepmc   +1 more source

LEP Experiments Committee: Minutes of the 44th meeting on 19 November 1996 [PDF]

, 1996
CERN. Geneva. LEP Experiments Committee
core  

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

A Critical Evaluation of the Limiting Current Density in Polymer Electrolytes: Interplay of Ion Transport, Mechanical Stability, and Conformal Li-Electrolyte Interfaces. [PDF]

J Am Chem Soc
Röring P, Pleie J, Butzelaar AJ, Overhoff GM, Schmidt C, Neuhaus K, Théato P, Winter M, Brunklaus G.   +8 more
europepmc   +1 more source

Minutes of the 56th meeting, 3 November 2000 [PDF]

, 2000
CERN. Geneva. LEP Experiments Committee
core  

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source

Dynamic activity of Erg promotes maturation of the hematopoietic system. [PDF]

Blood Adv
Tanaka-Yano M, Sugden WW, Wang D, Falchetti M, Badalamenti B, Côté P, Chin D, Goldstein J, George S, Rodrigues-Luiz GF, Lummertz da Rocha E, Li H, North TE, Gryder BE, Rowe RG.   +14 more
europepmc   +1 more source